Survival Rates for Massive Liver Cancer

Massive liver cancer typically carries a poor prognosis, with patients facing an average survival period of only about 3 to 6 months. Liver cancer is a highly aggressive malignancy, and when the tumor exceeds a diameter of 10–15 cm, it is classified as massive liver cancer. Due to its size, this type of cancer often leads to severe complications such as tumor rupture with internal bleeding or liver failure, which significantly worsen the patient's outlook.

At this advanced stage, curative treatments like surgery or interventional procedures are often no longer viable options. As a result, the focus typically shifts to palliative care, aiming to relieve symptoms and improve quality of life. Treatment may involve targeted drug therapies or traditional herbal medicine to help slow disease progression and ease discomfort.

In addition to medical interventions, supportive care plays a crucial role in managing symptoms. Pain management, nutritional support, and other comfort measures are commonly employed to enhance patient well-being and potentially extend survival time.

Ultimately, the goal of treatment becomes more about comfort than cure, emphasizing the importance of a personalized and compassionate approach to care for those living with this aggressive form of liver cancer.